Project Details
Description
A Phase 3 Open-Label, Randomized, Multicenter Study of NKTR-102 versus Treatment of Physicians Choice (TPC) in Patients with Locally Recurrent or Metastatic Breast Cancer Previously Treated with an Anthracycline, a Taxane, and Capecitabine, as amended.
| Status | Finished |
|---|---|
| Effective start/end date | 1/4/12 → 1/30/16 |
Funding
- NEKTAR THERAPEUTICS
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.